Lin et al. [97] analyzed serum samples from CA19-9-negative (n = 34) and -positive (n = 44) patients with PC and healthy controls (n = 36) and reported the diagnostic usefulness of Apo-AI and transferrin (TF) concentrations as biomarkers in CA19-9-negative PC patients. Here, APOA1 is linked to pachyonychia congenita.